As of 2024-10-10, the Relative Valuation of Anika Therapeutics Inc (ANIK) is (119.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.53 USD, the upside of Anika Therapeutics Inc based on Relative Valuation is -567.3%.
The range of the Relative Valuation is (58.64) - (126.41) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.7x - 31.2x | 25.8x |
| Forward P/E multiples | 9.5x - 25.2x | 21.8x |
| Fair Price | (58.64) - (126.41) | (119.29) |
| Upside | -329.7% - -595.1% | -567.3% |
| Date | P/E |
| 2024-10-10 | -4.97 |
| 2024-10-09 | -5.09 |
| 2024-10-08 | -4.92 |
| 2024-10-07 | -4.86 |
| 2024-10-04 | -4.99 |
| 2024-10-03 | -5.04 |
| 2024-10-02 | -4.99 |
| 2024-10-01 | -4.84 |
| 2024-09-30 | -4.93 |
| 2024-09-27 | -4.90 |
| 2024-09-26 | -4.91 |
| 2024-09-25 | -4.93 |
| 2024-09-24 | -4.93 |
| 2024-09-23 | -4.99 |
| 2024-09-20 | -5.09 |
| 2024-09-19 | -5.06 |
| 2024-09-18 | -5.08 |
| 2024-09-17 | -5.03 |
| 2024-09-16 | -4.96 |
| 2024-09-13 | -4.92 |
| 2024-09-12 | -4.87 |
| 2024-09-11 | -4.84 |
| 2024-09-10 | -4.91 |
| 2024-09-09 | -4.84 |
| 2024-09-06 | -4.90 |
| 2024-09-05 | -5.05 |
| 2024-09-04 | -5.02 |
| 2024-09-03 | -5.02 |
| 2024-08-30 | -5.13 |
| 2024-08-29 | -5.11 |
| 2024-08-28 | -5.16 |
| 2024-08-27 | -5.00 |
| 2024-08-26 | -5.05 |
| 2024-08-23 | -5.11 |
| 2024-08-22 | -4.95 |
| 2024-08-21 | -5.12 |
| 2024-08-20 | -5.14 |
| 2024-08-19 | -5.34 |
| 2024-08-16 | -5.11 |
| 2024-08-15 | -5.10 |
| 2024-08-14 | -5.05 |
| 2024-08-13 | -4.99 |
| 2024-08-12 | -5.00 |
| 2024-08-09 | -5.12 |
| 2024-08-08 | -5.12 |
| 2024-08-07 | -5.18 |
| 2024-08-06 | -5.20 |
| 2024-08-05 | -5.14 |
| 2024-08-02 | -5.19 |
| 2024-08-01 | -5.25 |